Vaccines for preventing influenza in healthy children (Q24201525)

1 July 2019

meta-analysis

0 references

title

Vaccines for preventing influenza in healthy children (English)

1 reference

1 July 2019

author

Vittorio Demicheli

4

0 references

Carlo Di Pietrantonj

3

0 references

Tom Jefferson

1

object named as

Tom Jefferson

1 reference

1 July 2019

Alessandro Rivetti

2

object named as

Alessandro Rivetti

1 reference

1 July 2019

Eliana Ferroni

5

object named as

Eliana Ferroni

1 reference

1 July 2019

publication date

15 August 2012

1 reference

1 July 2019

Cochrane Database of Systematic Reviews

published in

1 reference

1 July 2019

page(s)

CD004879

1 reference

1 July 2019

issue

8

1 reference

1 July 2019

Study of live recombinant cold-adapted influenza bivalent vaccine of type A for use in children: an epidemiological control trial

cites work

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004879.PUB4

The efficacy of live attenuated, cold-adapted, trivalent, intranasal influenzavirus vaccine in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004879.PUB4

Safety of the trivalent, cold-adapted influenza vaccine in preschool-aged children

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004879.PUB4

Efficacy of vaccination with live attenuated, cold-adapted, trivalent, intranasal influenza virus vaccine against a variant (A/Sydney) not contained in the vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004879.PUB4

Evaluation of a Neuraminidase-Specific Influenza A Virus Vaccine in Children: Antibody Responses and Effects on Two Successive Outbreaks of Natural Infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004879.PUB4

Comparison of heterotypic protection against influenza A/Taiwan/86 (H1N1) by attenuated and inactivated vaccines to A/Chile/83-like viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004879.PUB4

Effectiveness of inactivated influenza vaccine in preventing acute otitis media in young children: a randomized controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004879.PUB4

Comparison of US inactivated split-virus and Russian live attenuated, cold-adapted trivalent influenza vaccines in Russian schoolchildren

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004879.PUB4

Socioeconomic impact of influenza on healthy children and their families

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004879.PUB4

Efficacy of live attenuated and inactivated influenza vaccines in schoolchildren and their unvaccinated contacts in Novgorod, Russia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004879.PUB4

Efficacy and safety of a live attenuated, cold-adapted influenza vaccine, trivalent against culture-confirmed influenza in young children in Asia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004879.PUB4

Safety, efficacy, and effectiveness of cold-adapted influenza vaccine-trivalent against community-acquired, culture-confirmed influenza in young children attending day care

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004879.PUB4

Single-Dose Trials of Monovalent A/New Jersey/76 (Hsw1N1) Influenza Virus Vaccine in Children in Durham, North Carolina

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004879.PUB4

Safety and immunogenicity of low and high doses of trivalent live cold-adapted influenza vaccine administered intranasally as drops or spray to healthy children

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004879.PUB4

Monovalent Inactivated A/New Jersey/8/76 (Hsw1N1) Vaccine in Healthy Children Aged Three to Five Years

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004879.PUB4

Safety and immunogenicity following administration of a live, attenuated monovalent 2009 H1N1 influenza vaccine to children and adults in two randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004879.PUB4

Influenza A (H1N1) 2009 two-dose immunization of US children: an observer-blinded, randomized, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004879.PUB4

Class-specific antibody responses in school children vaccinated with an A/Brazil/11/78 (H1N1)-like recombinant influenza virus prepared from the A/Leningrad/134/57 paediatric cold-adapted donor strain

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004879.PUB4

Comparison of live attenuated cold-adapted and avian-human influenza A/Bethesda/85 (H3N2) reassortant virus vaccines in infants and children

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004879.PUB4

The A/Mallard/6750/78 avian-human, but not the A/Ann Arbor/6/60 cold-adapted, influenza A/Kawasaki/86 (H1N1) reassortant virus vaccine retains partial virulence for infants and children

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004879.PUB4

Clinical reactions and serologic response following inactivated monovalent influenza type B vaccine in young children and infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004879.PUB4

Prospective, randomized, placebo-controlled evaluation of the safety and immunogenicity of three lots of intranasal trivalent influenza vaccine among young children

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004879.PUB4

Vaccine effectiveness against laboratory-confirmed influenza in infants: A matched case control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004879.PUB4

Vaccine effectiveness against laboratory-confirmed influenza in children 6 to 59 months of age during the 2003-2004 and 2004-2005 influenza seasons

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004879.PUB4

Effectiveness of pandemic H1N1 vaccine against influenza-related hospitalization in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004879.PUB4

Various factors associated with the manifestation of influenza-like illness

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004879.PUB4

Effectiveness of the pandemic H1N1 influenza vaccines against laboratory-confirmed H1N1 infections: population-based case-control study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004879.PUB4

Vaccine effectiveness for laboratory-confirmed influenza in children 6-59 months of age, 2005-2007.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004879.PUB4

Estimates of pandemic influenza vaccine effectiveness in Europe, 2009-2010: results of Influenza Monitoring Vaccine Effectiveness in Europe (I-MOVE) multicentre case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004879.PUB4

Protective effect of single-dose adjuvanted pandemic influenza vaccine in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004879.PUB4

Assessment of effectiveness of Vaxigrip

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004879.PUB4

A prospective, Internet-based study of the effectiveness and safety of influenza vaccination in the 2001–2002 influenza season

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004879.PUB4

Effectiveness of an adjuvanted monovalent vaccine against the 2009 pandemic strain of influenza A(H1N1)v, in Stockholm County, Sweden

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004879.PUB4

Effectiveness of inactivated influenza vaccine for prevention of otitis media in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004879.PUB4

Effectiveness of virosomal subunit influenza vaccine in preventing influenza-related illnesses and its social and economic consequences in children aged 3-14 years: a prospective cohort study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004879.PUB4

Pilot study of influenza vaccine effectiveness in urban Australian children attending childcare

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004879.PUB4

An integrated, multistudy analysis of the safety of Ann Arbor strain live attenuated influenza vaccine in children aged 2-17 years

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004879.PUB4

A comparison of live and killed influenza-virus vaccines. Report to the Medical Research Council's Committee on Influenza and other Respiratory Virus Vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004879.PUB4

Correlates of immune protection induced by live, attenuated, cold-adapted, trivalent, intranasal influenza virus vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004879.PUB4

Safety and efficacy of live attenuated influenza vaccine in children 2-7 years of age.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004879.PUB4

Safety of cold-adapted live attenuated influenza vaccine in a large cohort of children and adolescents

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004879.PUB4

Efficacy of live attenuated influenza A/Scotland/74 (H3N2) virus vaccine against challenge with influenza A/Victoria/3/75 (H3N2) virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004879.PUB4

Clinical Trials with Inactivated Monovalent (A/New Jersey/76) and Bivalent (A/New Jersey /76-A/Victoria/75) Influenza Vaccines in Los Angeles Children

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004879.PUB4

Use of influenza A virus vaccines in seronegative children: live cold-adapted versus inactivated whole virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004879.PUB4

Influenza B Virus Vaccines in Children and Adults: Adverse Reactions, Immune Response, and Observations in the Field

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004879.PUB4

Safety of the trivalent inactivated influenza vaccine among children: a population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004879.PUB4

Influenza vaccine effectiveness and confounding factors among young children

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004879.PUB4

Direct and total effectiveness of the intranasal, live-attenuated, trivalent cold-adapted influenza virus vaccine against the 2000-2001 influenza A(H1N1) and B epidemic in healthy children

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004879.PUB4

Safety and immunogenicity of a purified haemagglutinin antigen in very young high-risk children

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004879.PUB4

Safety and immunogenicity of a purified F protein respiratory syncytial virus (PFP-2) vaccine in seropositive children with bronchopulmonary dysplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004879.PUB4

Reactogenicity and Immunogenicity of Bivalent Influenza Vaccine in One- and Two-Dose Trials in Children: A Summary

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004879.PUB4

A Controlled Double-Blind Comparison of Reactogenicity, Immunogenicity, and Protective Efficacy of Whole-Virus and Split-Product Influenza Vaccines in Children

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004879.PUB4

Comparison of monovalent and trivalent live attenuated influenza vaccines in young children

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004879.PUB4

Narcolepsy with cataplexy associated with H1N1 vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004879.PUB4

Safety and immunogenicity of a trivalent, inactivated, mammalian cell culture-derived influenza vaccine in healthy adults, seniors, and children

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004879.PUB4

Incidence of influenza in Finnish children

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004879.PUB4

Assessment of inactivated influenza-A vaccine after three outbreaks of influenza A at Christ's Hospital

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004879.PUB4

Effectiveness of influenza vaccination of day care children in reducing influenza-related morbidity among household contacts

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004879.PUB4

Effects of influenza plus pneumococcal conjugate vaccination versus influenza vaccination alone in preventing respiratory tract infections in children: a randomized, double-blind, placebo-controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004879.PUB4

A/New Jersey/76 influenza vaccine trial in seronegative schoolchildren: Comparison of a subunit vaccine with a whole-virus vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004879.PUB4

Safety, vaccine virus shedding and immunogenicity of trivalent, cold-adapted, live attenuated influenza vaccine administered to human immunodeficiency virus-infected and noninfected children

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004879.PUB4

Developments in mucosal influenza virus vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004879.PUB4

An Attenuated Influenza Virus Vaccine: Reactogenicity, Transmissibility, Immunogenicity, and Protective Efficacy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004879.PUB4

Reactivity and Immunogenicity of Monovalent A/New Jersey/76 Influenza Virus Vaccines in Children

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004879.PUB4

A TritonX-100-split virion influenza vaccine is safe and fulfills the committee for proprietary medicinal products (CPMP) recommendations for the European Community for Immunogenicity, in Children, Adults and the Elderly.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004879.PUB4

Cost-effectiveness analysis of an intranasal influenza vaccine for the prevention of influenza in healthy children

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004879.PUB4

Immunisation against influenza with a new subunit vaccine tested on children at risk (author's transl)

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004879.PUB4

Efficacy of intranasal virosomal influenza vaccine in the prevention of recurrent acute otitis media in children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004879.PUB4

Inactivated influenza vaccine (IIV) in children <2 years of age: examination of selected adverse events reported to the Vaccine Adverse Event Reporting System (VAERS) after thimerosal-free or thimerosal-containing vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004879.PUB4

Safety, efficacy and effectiveness of the influenza virus vaccine, trivalent, types A and B, live, cold-adapted (CAIV-T) in healthy children and healthy adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004879.PUB4

Three year follow up study of national influenza vaccination practices in Japan

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004879.PUB4

Adverse Events Following Trivalent Inactivated Influenza Vaccination in Children: Analysis of the Vaccine Adverse Event Reporting System

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004879.PUB4

Immunogenicity and Reactogenicity of 1 versus 2 Doses of Trivalent Inactivated Influenza Vaccine in Vaccine‐Naive 5–8‐Year‐Old Children

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004879.PUB4

Clinical and immunologic evaluation of neuraminidase-specific influenza A virus vaccine in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004879.PUB4

Studies on reactogenicity and immunogenicity of attenuated bivalent cold recombinant influenza type A (CRA) and inactivated trivalent influenza virus (TI) vaccines in infants and young children

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004879.PUB4

Safety of the trivalent, cold-adapted influenza vaccine (CAIV-T) in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004879.PUB4

Risk factors associated with severe influenza infections in childhood: implication for vaccine strategy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004879.PUB4

A randomized, double blind study in young healthy adults comparing cell mediated and humoral immune responses induced by influenza ISCOM? vaccines and conventional vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004879.PUB4

Comparison of immunogenicity and safety of a virosome influenza vaccine with those of a subunit influenza vaccine in pediatric patients with cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004879.PUB4

Risk of convulsions in children after monovalent H1N1 (2009) and trivalent influenza vaccines: a database study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004879.PUB4

Efficacy of inactivated vaccine in preventing antigenically drifted influenza type A and well-matched type B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004879.PUB4

A Clinical Trial with Monovalent Influenza A/New Jersey/76 Virus Vaccine in Preschool and School-Age Children

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004879.PUB4

Vaccinations May Induce Diabetes-Related Autoantibodies in One-Year-Old Children

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004879.PUB4

Reactions and serologic responses after administration of inactivated monovalent influenza A/swine virus vaccines. II. Immunization of children with influenza A/New Jersey/X-53 virus vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004879.PUB4

Reactions and Serologic Responses after Administration of Inactivated Monovalent Influenza A/Swine Virus Vaccines. I. Immunization of Children and Adults with Influenza A/Shope Virus Vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004879.PUB4

From the National Institute of Allergy and Infectious Diseases of the National Institutes of Health, the Center for Disease Control, and the Bureau of Biologics of the Food and Drug Administration. Summary of clinical trials of influenza vaccines--I

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004879.PUB4

Safety and effectiveness of a 2009 H1N1 vaccine in Beijing

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004879.PUB4

Recommendations for influenza immunization of children

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004879.PUB4

Efficacy of live attenuated influenza vaccine in children 6 months to 17 years of age.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004879.PUB4

Live attenuated influenza vaccine (FluMist®; Fluenz™): a review of its use in the prevention of seasonal influenza in children and adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004879.PUB4

Correlation of cellular immune responses with protection against culture-confirmed influenza virus in young children

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004879.PUB4

Publication delay of randomized trials on 2009 influenza A (H1N1) vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004879.PUB4

Influenza and the rates of hospitalization for respiratory disease among infants and young children

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004879.PUB4

Relation of study quality, concordance, take home message, funding, and impact in studies of influenza vaccines: systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004879.PUB4

Vaccines for preventing influenza in healthy adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004879.PUB4

Universal vaccination of children against influenza: are there indirect benefits to the community? A systematic review of the evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004879.PUB4

Meta-analysis of the immunogenicity and tolerability of pandemic influenza A 2009 (H1N1) vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004879.PUB4

A systematic review of the evidence on the effectiveness and risks of inactivated influenza vaccines in different target groups

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004879.PUB4

The effect of influenza on hospitalizations, outpatient visits, and courses of antibiotics in children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004879.PUB4

Efficacy and effectiveness of influenza vaccines: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004879.PUB4

Are we ready for universal influenza vaccination in paediatrics?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004879.PUB4

The Japanese experience with vaccinating schoolchildren against influenza

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004879.PUB4

Efficacy of live attenuated influenza vaccine in children: A meta-analysis of nine randomized clinical trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004879.PUB4

Safety of pandemic H1N1 vaccines in children and adolescents

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004879.PUB4

Immunogenicity and safety of pandemic influenza A (H1N1) 2009 vaccine: systematic review and meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004879.PUB4

Vaccines for preventing influenza in healthy children

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004879.PUB4

Efficacy and safety of 1 and 2 doses of live attenuated influenza vaccine in vaccine-naive children

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004879.PUB4

Ramifications of adverse events in children in Australia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004879.PUB4

Influenza vaccine in healthy children: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004879.PUB4

Mucosal immune response to trivalent live attenuated intranasal influenza vaccine in children

21 January 2018

1 reference

12 December 2020

Estimation of the efficacy of live, attenuated influenza vaccine from a two-year, multi-center vaccine trial: implications for influenza epidemic control

1 reference

12 December 2020

[The evaluation of the reactogenicity, harmlessness and prophylactic efficacy of Grippol trivalent polymer-subunit influenza vaccine administered to schoolchildren]

1 reference

12 December 2020

Prevention of otitis media in children with live attenuated influenza vaccine given intranasally

1 reference

12 December 2020

Safety and immunogenicity of adjuvanted and unadjuvanted subunit influenza vaccines administered intranasally to healthy adults

1 reference

12 December 2020

Studies of the 1996-1997 inactivated influenza vaccine among children attending day care: immunologic response, protection against infection, and clinical effectiveness

1 reference

12 December 2020

Does influenza vaccination prevent asthma exacerbations in children?

1 reference

12 December 2020

Influenza vaccine in healthy preschool children

1 reference

12 December 2020

Compliance with influenza vaccination in Israel in two successive winters, 1998/1999 and 1999/2000.

1 reference

12 December 2020

Evaluation of a live, attenuated recombinant influenza vaccine in high school children

1 reference

12 December 2020

Efficacy of inactivated and cold-adapted vaccines against influenza A infection, 1985 to 1990: the pediatric experience

1 reference

12 December 2020

Prophylactic effect of inactivated influenza vaccine on young children

1 reference

12 December 2020

The investigation of the safety, genetic stability and immunogenicity of live influenza vaccine for adults in vaccination of 3-6 years old children

1 reference

12 December 2020

[The comparative characteristics of the safety, immunogenic activity and prophylactic potency of the adult and children types of live influenza vaccine in schoolchildren aged 7-14 years]

1 reference

12 December 2020

[Influence of multiplicity of immunizations of children with inactivated influenza vaccine on immune response and the effectiveness of protection]

1 reference

12 December 2020

Safety and immunogenicity of a live-attenuated influenza vaccine blended and filled at two manufacturing facilities

1 reference

12 December 2020

FluMist: an intranasal live influenza vaccine

1 reference

12 December 2020

Influenza vaccination in a residential boys' school; report to the medical research council committee on clinical trials of influenza vaccine.

1 reference

12 December 2020

Evaluation of a cold-adapted influenza B/Texas/84 reassortant virus (CRB-87) vaccine in young children

1 reference

12 December 2020

A TRIAL OF OIL-ADJUVANT INFLUENZA VACCINE IN A NON-EPIDEMIC SEASON

1 reference

12 December 2020

A COMPARATIVE TRIAL OF OIL-ADJUVANT AND AQUEOUS POLYVALENT INFLUENZA VACCINES

1 reference

12 December 2020

Failure of inactivated influenza A vaccine to protect healthy children aged 6-24 months

1 reference

12 December 2020

Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP)

1 reference

12 December 2020

An Advisory Committee Statement (ACS). National Advisory Committee on Immunization (NACI). Statement on influenza vaccination for the 2004-2005 season

1 reference

12 December 2020

Immunization of infants and young children with live attenuated trivalent cold-recombinant influenza A H1N1, H3N2, and B vaccine

1 reference

12 December 2020

Total immunization of children against influenza decreases morbidity in a number of diseases among elderly persons during influenza epidemic

1 reference

12 December 2020

Assessment of the efficacy and effectiveness of influenza vaccines in healthy children: systematic review

1 reference

12 December 2020

Outbreak of influenza A (H3N2) in a highly-vaccinated religious community: a retrospective cohort study.

1 reference

12 December 2020

An outbreak of influenza A (H3N2) in a well immunized nursing home population

1 reference

12 December 2020

Effectiveness of the 2003-2004 influenza vaccine among children 6 months to 8 years of age, with 1 vs 2 doses

1 reference

12 December 2020

Safety of influenza vaccines in children

1 reference

12 December 2020

Inactivated influenza vaccine effectiveness in children under 6 years of age during the 2002-2003 season

1 reference

12 December 2020

The safety of trivalent influenza vaccine among healthy children 6 to 24 months of age

1 reference

12 December 2020

Effectiveness of vaccine against medical consultation due to laboratory-confirmed influenza: results from a sentinel physician pilot project in British Columbia, 2004-2005

1 reference

12 December 2020

The impact of mass school immunization on school attendance

1 reference

12 December 2020

Safety of trivalent inactivated influenza vaccine in children 6 to 23 months old.

1 reference

12 December 2020

Influenza vaccine effectiveness in healthy 6- to 21-month-old children during the 2003-2004 season

1 reference

12 December 2020

Effectiveness of school-based influenza vaccination

1 reference

12 December 2020

The efficacy of influenza vaccine for healthy children: a meta-analysis evaluating potential sources of variation in efficacy estimates including study quality

1 reference

12 December 2020

Prevention and control of influenza. Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2007.

1 reference

12 December 2020

The inoculation properties of live recombinant influenza vaccine types A and B used separately and jointly in children 3 to 14

1 reference

12 December 2020

A comparative study of the inoculation properties of live recombinant and inactivated influenza vaccines made from strain A/Philippines/2/82 (H3N2) in 8- to 15-year-old children

1 reference

12 December 2020

[A comparative study of the protective properties of live recombinant and inactivated influenza vaccines made from strain A/Philippines/2/82 (H3N2) in 8- to 15-year-old children].

1 reference

12 December 2020

Influenza vaccine concurrently administered with a combination measles, mumps, and rubella vaccine to young children

1 reference

12 December 2020

Prevention and control of influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2010.

1 reference

12 December 2020

Vaccine Effectiveness Against Laboratory-confirmed Influenza in Healthy Young Children

1 reference

12 December 2020

Differences in national influenza vaccination policies across the European Union, Norway and Iceland 2008-2009.

1 reference

12 December 2020

Early estimates of seasonal influenza vaccine effectiveness in Europe, 2010/11: I-MOVE, a multicentre case-control study.

1 reference

12 December 2020

Evaluation in children of cold-adapted influenza B live attenuated intranasal vaccine prepared by reassortment between wild-type B/Ann Arbor/1/86 and cold-adapted B/Leningrad/14/55 viruses

1 reference

12 December 2020

Prevention and control of influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2011.

1 reference

12 December 2020

I-MOVE multi-centre case control study 2010-11: overall and stratified estimates of influenza vaccine effectiveness in Europe

1 reference

12 December 2020

The efficacy of intranasal live attenuated influenza vaccine in children 2 through 17 years of age: a meta-analysis of 8 randomized controlled studies

1 reference

12 December 2020

Evaluation of adverse events after influenza vaccination in hospital personnel.

1 reference

12 December 2020

Live attenuated and inactivated influenza vaccine in school-age children

1 reference

12 December 2020

[Results of a study of the effectiveness of simultaneous immunization against influenza with live and inactivated vaccines (1980-1983)]

1 reference

12 December 2020

[Assessment of the prophylactic effectiveness of an inactivated influenza vaccine by immunizing schoolchildren in the springtime]

1 reference

12 December 2020

[The results of state trials of inactivated influenza vaccines for children]

1 reference

12 December 2020

[Results of a study of a live intranasal influenza vaccine in the immunization of children 3 to 15 years old]

1 reference

12 December 2020

[Characteristics of the clinical and immunologic safety of inactivated influenza vaccines in children undergoing multiple immunizations]

1 reference

12 December 2020

Results of coded trials of the activity of the trivalent subunit influenza vaccine Grippovak in Moscow kindergartens in December 1983 through the 1st quarter of 1984

1 reference

12 December 2020

A placebo-controlled dose-response study of the reactogenicity and immunogenicity of a cold-adapted recombinant A/Victoria/3/75 (H3N2) live influenza virus candidate vaccine in healthy volunteers

1 reference

12 December 2020

Basic results of a committee trial of the new vaccine Grippovac SE-AZh

1 reference

12 December 2020

[Results of a study of new preparations of inactivated whole-virion influenza vaccines for the protection of children in the USSR]

1 reference

12 December 2020

Vaccination of infants and schoolchildren with an influenza subunit vaccine (author's transl)

1 reference

12 December 2020

Simultaneous administration of live, attenuated influenza A vaccines representing different serotypes

1 reference

12 December 2020

Protective efficacy of live influenza vaccines. Its assessment in field and experimental conditions

1 reference

12 December 2020

Controlled trial of inactivated influenza vaccine containing the a-Hong Kong strain during an outbreak of influenza due to the a-England-42-72 strain

1 reference

12 December 2020

Protection with split and whole virus vaccines against influenza

1 reference

12 December 2020

[Results of studying the effectiveness of a live influenza vaccine for peroral use on preschool and schoolchildren]

1 reference

12 December 2020

Field trial with human and equine influenza vaccines in children: protection and antibody titres

1 reference

12 December 2020

Cell-mediated immune responses to the hemagglutinin and neuraminidase antigens of influenza A virus after immunization in humans

1 reference

12 December 2020

The effect of vaccine on a closed epidemic of Hong Kong influenza

1 reference

12 December 2020

The effectiveness of influenza prevention with a special variation of live influenza vaccine for children in the 1969 epidemic

1 reference

12 December 2020

Modification of an Outbreak of Influenza in Tecumseh, Michigan by Vaccination of Schoolchildren

1 reference

12 December 2020

Evaluation of monovalent and polyvalent influenza vaccines during an epidemic of type A2 and B influenza

1 reference

12 December 2020

Use of influenza vaccine in non-high risk populations

1 reference

12 December 2020

Summary of Clinical Trials of Inactivated Influenza Vaccine--1978

1 reference

12 December 2020

[Preliminary results of a trial of a highly purified inactivated chromatographic influenza vaccine for children]

1 reference

12 December 2020

[Evaluation of the safety, reactogenicity and antigenic activity of inactivated chromatographic influenza vaccine in school children]

1 reference

12 December 2020

Potential for single high-dose influenza immunization in unprimed children

1 reference

12 December 2020

Influenza A vaccine decreases the incidence of otitis media in 6- to 30-month-old children in day care

1 reference

12 December 2020

Safety and immunogenicity of a cold-adapted influenza A (H1N1) reassortant virus vaccine administered to infants less than six months of age.

1 reference

12 December 2020

Clinical evaluation of neuraminidase monospecific (HEqN2) recombinant influenza vaccine in children

1 reference

12 December 2020

Natural challenge of subjects vaccinated with WRL 105 strain live influenza vaccine in a residential community

1 reference

12 December 2020

A comparative study of live and inactivated influenza vaccines: the organization of the observation and the results of a study of their reactogenicity and immunogenicity

1 reference

12 December 2020

[The immunogenic properties and prophylactic efficacy of a live polyvalent influenza vaccine in children 5 to 14 years old]

1 reference

12 December 2020

Multidose, live attenuated, cold-recombinant, trivalent influenza vaccine in infants and young children

1 reference

12 December 2020

A randomized controlled trial of cold-adapted and inactivated vaccines for the prevention of influenza A disease

1 reference

12 December 2020

Comparison of live attenuated and inactivated influenza vaccines in schoolchildren in Russia: I. Safety and efficacy in two Moscow schools, 1987/88

2 references

12 December 2020

https://api.crossref.org/works/10.1002%2F14651858.CD004879.PUB4

7 January 2021

inferred from DOI database lookup

Evaluation of live attenuated influenza vaccines in children 6-18 months of age: safety, immunogenicity, and efficacy. National Institute of Allergy and Infectious Diseases, Vaccine and Treatment Evaluation Program and the Wyeth-Ayerst ca Influenza

1 reference

12 December 2020

Clinical and epidemiological evaluation of a live, cold-adapted influenza vaccine for 3-14-year-olds.

1 reference

12 December 2020

[Prophylactic effectiveness of a live recombinant influenza type A vaccine in immunizing children aged 3-14 years]

1 reference

12 December 2020

Immunogenicity and safety of influenza vaccination in 3- to 6-year-old children with a two dose immunisation schedule

1 reference

12 December 2020

Immunogenicity and tolerability of a trivalent influenza subunit vaccine (Influvac) in high-risk children aged 6 months to 4 years.

1 reference

12 December 2020

Evaluation of bivalent live attenuated influenza A vaccines in children 2 months to 3 years of age: safety, immunogenicity and dose-response

1 reference

12 December 2020

[Evaluation of the effectiveness of influenza trivalent polymer subunit vaccine "Grippol"]

1 reference

12 December 2020

Adverse effects associated with influenza vaccine in pediatrics

1 reference

12 December 2020

Influenza vaccine in immunogenically naive healthy infants

1 reference

12 December 2020

10.1002/14651858.CD004879.PUB4

Identifiers

DOI

1 reference

1 July 2019

OpenCitations bibliographic resource ID

7326

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

1 reference

1 July 2019

PubMed ID

22895945

1 reference

1 July 2019